Home › Companies › ANI Pharmaceuticals, Inc. › 2024-2025
Compiled from SEC Form N-PX filings and ANI Pharmaceuticals, Inc.’s Form 8-K (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore ANI Pharmaceuticals, Inc. in the interactive database Compare manager voting policies
These tallies are ANI Pharmaceuticals, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Thomas Haughey | 15,977,793 | 285,277 | 7,168 | -- | 2,151,848 | Majority: yes |
| Elect Director: Nikhil Lalwani | 16,238,474 | 27,618 | 4,146 | -- | 2,151,848 | Majority: yes |
| Elect Director: Matthew J. Leonard, R.Ph. | 15,996,996 | 266,074 | 7,168 | -- | 2,151,848 | Majority: yes |
| Elect Director: Antonio R. Pera | 15,507,112 | 755,808 | 7,318 | -- | 2,151,848 | Majority: yes |
| Elect Director: Muthusamy Shanmugam | 16,202,753 | 63,027 | 4,458 | -- | 2,151,848 | Majority: yes |
| Elect Director: Renee P. Tannenbaum, Pharm.D. | 14,548,200 | 1,368,462 | 353,576 | -- | 2,151,848 | Majority: yes |
| Elect Director: Jeanne A. Thoma | 15,581,643 | 684,634 | 3,961 | -- | 2,151,848 | Majority: yes |
| Elect Director: Patrick D. Walsh | 16,145,463 | 120,797 | 3,978 | -- | 2,151,848 | Majority: yes |
| Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year endi | 18,376,994 | 37,343 | 7,749 | -- | -- | Majority: yes |
| Proposal 3: Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers, on an advisory basis, was as follows: | 14,565,587 | 1,689,477 | 15,174 | -- | 2,151,848 | Majority: yes |
| Proposal 4: Approval of an Amendment to the Company's Restated Certificate of Incorporation The vote with respect to the approval of an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock | 17,950,106 | 461,824 | 10,156 | -- | -- | Majority: yes |
| Proposal 5: Approval of the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan was as follows: | 15,056,885 | 1,202,893 | 10,460 | -- | 2,151,848 | Majority: yes |
| Proposal 6: Approval of the Amended 2016 Employee Stock Purchase Plan The vote with respect to the approval of the Amended 2016 Employee Stock Purchase Plan was as follows: | 16,173,976 | 89,098 | 7,164 | -- | 2,151,848 | Majority: yes |
Source: ANI Pharmaceuticals, Inc., Form 8-K — read the filing on EDGAR.
Each item below shows how the 269 asset managers that disclosed a ANI Pharmaceuticals, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ANI Pharmaceuticals, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Proposal 3: Approval of the Say-on-Pay Proposal The vote with respect to the approval of the Company's named executive officers, on an advisory basis, was as follows:”): 14,565,587 for, 1,689,477 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 69% for, 8% against (77% of the company cast a for/against vote).
The 266 asset managers below cast 88% of the shares they voted on this item FOR (13,385,646 for, 1,798,916 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,196,894 | 265 | 0 | 0 | For |
| Vanguard | 1,228,580 | 478 | 0 | 0 | For |
| State Street | 945,289 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 773,883 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 565,145 | 0 | 0 | Against |
| Global Alpha Capital Management Ltd. | 0 | 505,635 | 0 | 0 | Against |
| Ranger Investment Management, L.P. | 472,908 | 0 | 0 | 0 | For |
| Dimensional | 466,347 | 0 | 0 | 0 | For |
| Charles Schwab | 438,453 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 427,305 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 412,772 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 401,826 | 0 | 0 | 0 | For |
| Fidelity | 394,814 | 0 | 0 | 0 | For |
| Citadel | 373,705 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Russell Investments | 250,081 | 0 | 0 | 0 | For |
| Invesco | 0 | 233,509 | 0 | 0 | Against |
| Loomis Sayles | 231,512 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 226,993 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| JPMorgan | 194,971 | 0 | 0 | 0 | For |
| Northern Trust | 193,829 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 191,328 | 0 | 0 | 0 | For |
| THOMPSON SIEGEL & WALMSLEY LLC | 177,562 | 0 | 0 | 0 | For |
Showing the 25 largest of 266 asset managers. See all 266 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Proposal 6: Approval of the Amended 2016 Employee Stock Purchase Plan The vote with respect to the approval of the Amended 2016 Employee Stock Purchase Plan was as follows:”): 16,173,976 for, 89,098 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 77% for, 0.5% against (77% of the company cast a for/against vote).
The 82 asset managers below cast 99.7% of the shares they voted on this item FOR (6,408,257 for, 16,410 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,579 | 0 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 1,630 | 0 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.
Combines 2 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Antonio R. Pera”): 15,507,112 for, 755,808 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 73% for, 4% against (77% of the company cast a for/against vote).
The 81 asset managers below cast 99.9% of the shares they voted on this item FOR (6,422,460 for, 133 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,578 | 1 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Jeanne A. Thoma”): 15,581,643 for, 684,634 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 74% for, 3% against (77% of the company cast a for/against vote).
The 81 asset managers below cast 99.9% of the shares they voted on this item FOR (6,422,460 for, 133 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,578 | 1 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Matthew J. Leonard, R.Ph.”): 15,996,996 for, 266,074 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 76% for, 1% against (77% of the company cast a for/against vote).
The 81 asset managers below cast 99.9% of the shares they voted on this item FOR (6,421,130 for, 1,463 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,102 | 477 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Muthusamy Shanmugam”): 16,202,753 for, 63,027 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 77% for, 0.3% against (77% of the company cast a for/against vote).
The 81 asset managers below cast 99.9% of the shares they voted on this item FOR (6,422,593 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,579 | 0 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Nikhil Lalwani”): 16,238,474 for, 27,618 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 77% for, 0.2% against (77% of the company cast a for/against vote).
The 81 asset managers below cast 99.9% of the shares they voted on this item FOR (6,422,593 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,579 | 0 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Renee P. Tannenbaum, Pharm.D.”): 14,548,200 for, 1,368,462 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 69% for, 6% against (75% of the company cast a for/against vote).
The 81 asset managers below cast 94% of the shares they voted on this item FOR (5,749,835 for, 363,212 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,100 | 478 | 1 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 309,545 | 0 | Abstain |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 275,941 | 0 | 0 | Against |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 0 | 47,036 | 0 | 0 | Against |
| Securian Funds Trust | 0 | 36,827 | 0 | 0 | Against |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Thomas Haughey”): 15,977,793 for, 285,277 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 76% for, 1% against (77% of the company cast a for/against vote).
The 81 asset managers below cast 99.9% of the shares they voted on this item FOR (6,421,130 for, 1,463 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,102 | 477 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Proposal 4: Approval of an Amendment to the Company's Restated Certificate of Incorporation The vote with respect to the approval of an amendment to the Company's Restated Certificate of Incorporation to increase the num”): 17,950,106 for, 461,824 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 85% for, 2% against (87% of the company cast a for/against vote).
The 81 asset managers below cast 99.7% of the shares they voted on this item FOR (6,405,942 for, 18,281 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,579 | 0 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,266 | 10 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 1,630 | 0 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of EisnerAmper LLP as the Company's independent registered public ”): 18,376,994 for, 37,343 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 87% for, 0.2% against (87% of the company cast a for/against vote).
The 81 asset managers below cast 99.9% of the shares they voted on this item FOR (6,422,581 for, 12 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,579 | 0 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,264 | 12 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| Empower | 78,775 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.
93% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Proposal 5: Approval of the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan was as follows:”): 15,056,885 for, 1,202,893 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 71% for, 6% against (77% of the company cast a for/against vote).
The 80 asset managers below cast 98% of the shares they voted on this item FOR (6,297,108 for, 106,339 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Vanguard | 1,176,577 | 2 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,264 | 12 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| World Funds Trust | 6,350 | 77,956 | 0 | 0 | Against |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 1,630 | 0 | For |
| Empower | 60,757 | 0 | 0 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
Showing the 25 largest of 80 asset managers. See all 80 in the interactive database.
100% fund support · no official result
The 53 asset managers below cast 100% of the shares they voted on this item FOR (4,043,554 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,175,092 | 0 | 0 | 0 | For |
| Fidelity | 391,723 | 0 | 0 | 0 | For |
| Dimensional | 387,894 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 309,545 | 0 | 0 | 0 | For |
| State Street | 297,276 | 0 | 0 | 0 | For |
| Waddell & Reed | 275,941 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 201,990 | 0 | 0 | 0 | For |
| Aberdeen | 175,020 | 0 | 0 | 0 | For |
| Invesco | 96,937 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 65,600 | 0 | 0 | 0 | For |
| Empower | 60,757 | 0 | 0 | 0 | For |
| Brighthouse | 60,401 | 0 | 0 | 0 | For |
| Equitable | 47,745 | 0 | 0 | 0 | For |
| TIAA | 47,581 | 0 | 0 | 0 | For |
| Ivy Variable Insurance Portfolios | 47,036 | 0 | 0 | 0 | For |
| First Trust | 35,050 | 0 | 0 | 0 | For |
| Principal | 33,720 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY FUNDS /DE/ | 28,500 | 0 | 0 | 0 | For |
| Transamerica | 26,716 | 0 | 0 | 0 | For |
| American Century | 25,981 | 0 | 0 | 0 | For |
| Lincoln Financial | 25,806 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 21,694 | 0 | 0 | 0 | For |
| Northern Trust | 18,427 | 0 | 0 | 0 | For |
| BNY Mellon | 17,953 | 0 | 0 | 0 | For |
| SPEND LIFE WISELY FUNDS INVESTMENT TRUST | 16,541 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Patrick D. Walsh”): 16,145,463 for, 120,797 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,108,152 outstanding shares: 76% for, 0.6% against (77% of the company cast a for/against vote).
The 34 asset managers below cast 99.9% of the shares they voted on this item FOR (2,378,563 for, 476 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,605,972 | 0 | 0 | 0 | For |
| Charles Schwab | 210,573 | 0 | 0 | 0 | For |
| World Funds Trust | 84,306 | 0 | 0 | 0 | For |
| Russell Investments | 82,280 | 0 | 0 | 0 | For |
| JPMorgan | 72,576 | 0 | 0 | 0 | For |
| SEI | 51,292 | 0 | 0 | 0 | For |
| Loomis Sayles | 49,676 | 0 | 0 | 0 | For |
| Securian Funds Trust | 36,827 | 0 | 0 | 0 | For |
| Jackson National | 34,687 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 31,871 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 25,510 | 0 | 0 | 0 | For |
| Empower | 18,018 | 0 | 0 | 0 | For |
| Prudential/PGIM | 14,780 | 0 | 0 | 0 | For |
| Global X | 10,981 | 0 | 0 | 0 | For |
| SEI Exchange Traded Funds | 8,718 | 0 | 0 | 0 | For |
| John Hancock | 7,451 | 0 | 0 | 0 | For |
| Allianz | 6,190 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 5,276 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 4,918 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,867 | 0 | 0 | 0 | For |
| New York Life | 3,872 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 2,550 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 1,630 | 0 | Abstain |
| Vanguard | 1,011 | 476 | 0 | 0 | For |
| GPS Funds I | 1,253 | 0 | 0 | 0 | For |
Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.
95% fund support · no official result
The 3 asset managers below cast 95% of the shares they voted on this item FOR (18,018 for, 986 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 18,018 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 700 | 0 | 0 | Against |
| HC CAPITAL TRUST | 0 | 286 | 0 | 0 | Against |
Ranked by the number of ANI Pharmaceuticals, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 21,108,152 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 10.41% |
| 2 | Vanguard | 5.82% |
| 3 | State Street | 4.48% |
| 4 | Deep Track Capital, LP | 3.67% |
| 5 | Aberdeen | 2.68% |
| 6 | Global Alpha Capital Management Ltd. | 2.40% |
| 7 | Ranger Investment Management, L.P. | 2.24% |
| 8 | Dimensional | 2.21% |
| 9 | Charles Schwab | 2.08% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.02% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 12.54% | 13F |
| Vanguard Group | 5.60% | 13F |
| Meridian Venture Partners II, L.P. | 5.52% | DEF14A |
| Integrated Core Strategies (US) LLC | 5.25% | 13G |
| Meridian Venture Partners II GP, L.P. ("GP") | 4.81% | 13D |
| Millennium Management | 3.88% | 13F |
| Citadel Advisors | 3.48% | 13F |
| Muthusamy Shanmugam | 3.39% | DEF14A |
| State Street | 3.39% | 13F |
| Goldman Sachs | 2.99% | 13F |
Percentages above are of 21,108,152 shares outstanding, as reported by ANI Pharmaceuticals, Inc. on its Form 10-K dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANI Pharmaceuticals, Inc.’s 10-K dated 2024-12-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At ANI Pharmaceuticals, Inc.'s shareholder meeting held 2025-05-22, in the 2024-2025 proxy season, 269 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,724 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve the compensation of the Company's named executive officers, on a non-binding… — FOR was 90% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANI Pharmaceuticals, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).
ANI Pharmaceuticals, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.